ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 336

$899K Total Retail Price of All Prescriptions

Rank: 56 out of 336

723 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 723 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 723 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 16,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 736 630 1 3
HYDROCODONE-ACETAMINOPHEN 728 536 S3 2 2
LISINOPRIL 625 513 3 6
SIMVASTATIN 621 548 4 5
AMLODIPINE BESYLATE 585 500 5 1
PRAVASTATIN SODIUM 546 446 6 10
GABAPENTIN 478 421 7 11
METFORMIN HCL 469 339 8 8
METOPROLOL SUCCINATE 446 407 9 15
FUROSEMIDE 425 357 10 4
LEVOTHYROXINE SODIUM 402 353 11 7
HYDROCHLOROTHIAZIDE 364 334 12 12
ZOLPIDEM TARTRATE 341 247 13 18
ATORVASTATIN CALCIUM 340 294 14 14
BENAZEPRIL HCL 304 272 15 59
CARVEDILOL 290 215 16 13
CITALOPRAM HBR 285 255 17 21
PAROXETINE HCL 278 254 18 64
NEXIUM 272 223 19 24
TRAMADOL HCL 263 203 20 20
MELOXICAM 262 243 21 19
GLIMEPIRIDE 248 190 22 29
DICLOFENAC SODIUM 217 196 23 145
SYNTHROID 209 179 24 43
ALENDRONATE SODIUM 201 178 25 54
POTASSIUM CHLORIDE 198 180 26 9
TAMSULOSIN HCL 194 173 27 38
WARFARIN SODIUM 188 127 28 17
ALLOPURINOL 184 155 29 30
VENLAFAXINE HCL ER 177 98 30 100
LOSARTAN POTASSIUM 173 131 31 22
DONEPEZIL HCL 170 157 32 27
AMITRIPTYLINE HCL 163 148 R 33 57
FENOFIBRATE 159 143 34 72
CLOPIDOGREL 155 129 35 28
TRIAMTERENE-HCTZ 152 139 36 35
TRAZODONE HCL 148 124 37 46
NAMENDA 147 137 38 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 122 39 23
METOPROLOL TARTRATE 144 134 40 16
DIOVAN 144 144 40 31
RANITIDINE HCL 138 110 42 36
CYMBALTA 134 76 43 52
LOSARTAN-HYDROCHLOROTHIAZIDE 126 112 44 45
SERTRALINE HCL 125 102 45 33
CRESTOR 122 105 46 25
ISOSORBIDE MONONITRATE ER 116 96 47 44
ATENOLOL 114 86 48 26
PANTOPRAZOLE SODIUM 110 81 49 40
CLONIDINE HCL 106 93 50 32
PLAVIX 105 86 51 37
RAMIPRIL 105 76 51 84
AZITHROMYCIN 104 86 53 58
AMLODIPINE BESYLATE-BENAZEPRIL 95 71 54 47
DILTIAZEM 24HR CD 95 71 54 126
NAPROXEN 95 79 54 80
LOVASTATIN 92 81 57 34
CIPROFLOXACIN HCL 89 67 58 55
FLUTICASONE PROPIONATE 79 50 59 49
MECLIZINE HCL 78 75 60 96
ESCITALOPRAM OXALATE 77 65 61 69
SPIRONOLACTONE 74 53 62 42
TIZANIDINE HCL 74 39 62 83
METOLAZONE 73 52 64 170
CYCLOBENZAPRINE HCL 71 49 R 65 65
NITROSTAT 70 64 66 198
AGGRENOX 70 67 66 133
DIGOXIN 69 53 68 50
PRIMIDONE 66 65 69 220
LANTUS 62 32 70 56
VERAPAMIL ER 60 60 71 95
CARISOPRODOL 58 0 R 72 63
CELEBREX 58 53 72 105
KLOR-CON M20 57 41 74 51
DOXAZOSIN MESYLATE 56 55 75 86
DICYCLOMINE HCL 55 33 76 217
LANSOPRAZOLE 54 42 77 167
PROPRANOLOL HCL 54 40 77 101
LEXAPRO 52 46 79 197
PROAIR HFA 52 35 79 77
DIOVAN HCT 51 47 81 41
COUMADIN 51 47 81 266
ESTRADIOL 50 50 R 83 129
LABETALOL HCL 50 40 83 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.